Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

Cited by papers we hold 5

• Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy · 2024
  No notice
• Tumor-associated macrophages: an effective player of the tumor microenvironment · 2023
  No notice
• Targeting tumor-associated macrophages for cancer treatment · 2022
  No notice
• Targeting macrophages in hematological malignancies: recent advances and future directions · 2022
  No notice
• Targeting CD47 for cancer immunotherapy · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.